Position of the academy of nutrition and dietetics: Dietary fatty acids for healthy adults

Journal of the Academy of Nutrition and Dietetics

Volumn 114, Issue 1, 2014, Pages 136-153

  Vannice, Gretchen ^a   Rasmussen, Heather ^b  

^a Rush University Medical Center ^*

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; CALORIC INTAKE; CEREAL; DAIRY PRODUCT; DIET; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; DIETETICS; DIETITIAN; FAT INTAKE; FRUIT; HUMAN; MEAT; NUT; NUTRITIONAL VALUE; ORGANIZATION; PLANT SEED; SEA FOOD; STANDARD; VEGETABLE;

ACADEMIES AND INSTITUTES; ADULT; CEREALS; DAIRY PRODUCTS; DIET; DIETARY FATS; DIETARY SUPPLEMENTS; DIETETICS; ENERGY INTAKE; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-3; FRUIT; HUMANS; MEAT; NUTRITIONISTS; NUTRITIVE VALUE; NUTS; RECOMMENDED DIETARY ALLOWANCES; SEAFOOD; SEEDS; VEGETABLES;

EID: 84890169034     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2013.11.001     Document Type: Article

References (127)

1. Position of the American Dietetic Association and Dietitians of Canada: Dietary fatty acids. JAm Diet Assoc 2007, 107(9):1599-1611. American Dietetic Association, Dietitians of Canada.
2. National Cancer Institute. Sources of saturated fat, stearic acid, & cholesterol raising fat among the US population, 2005-06. Risk Factor Monitoring and Methods website. Updated 2010. Accessed August2012. http://riskfactor.cancer.gov/diet/foodsources/sat_fat/.
3. Lichtenstein A.H., Appel L.J., et al. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association nutrition committee. Circulation 2006, 114(1):82-96. American Heart Association Nutrition Committee.
4. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143-3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
5. US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans 2010. Updated 2012. Accessed August 12,2012. http://www.health.gov/dietaryguidelines/2010.asp.
6. Fats and fatty acids in human nutrition. Report of an expert consultation. FAO Food Nutr Pap 2010, 91:1-166.
7. The nomenclature of lipids (recommendations, 1976) IUPAC-IUB Commission on Biochemical Nomenclature. Biochem J 1978, 171(1):21-35.
8. Ratnayake W.M., Galli C. Fat and fatty acid terminology, methods of analysis and fatdigestion and metabolism: A background review paper. Ann Nutr Metab 2009, 55(1-3):8-43.
9. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Dietary Fats: Total Fat and Fatty Acids 2005, 422-541. Food and Nutrition Board Institute of Medicine, National Academies Press, Washington, DC.
10. US Department of Agriculture, Agricultural Research Service. Nutrient intakes from food: Mean amounts consumed per individual, by gender and age, what we eat in America, NHANES 2009-2010. Updated 2012. Accessed September 4,2012. http://www.ars.usda.gov/ba/bhnrc/fsrg.
11. Khaw K.T., Friesen M.D., Riboli E., Luben R., Wareham N. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: The EPIC-Norfolk prospective study. PLoS Med 2012, 9(7):e1001255.
12. Chiuve S.E., Rimm E.B., Sandhu R.K., et al. Dietary fat quality and risk of sudden cardiac death in women. Am J Clin Nutr 2012, 96(3):498-507.
13. US Department of Agriculture. USDA National Nutrient Database For Standard Reference. Updated 2011. Accessed September 2,2012. http://ndb.nal.usda.gov/.
14. Mozaffarian D. Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 2008, 87(6):1991S-1996S.
15. Nicolosi R.J. Dietary fat saturation effects on low-density-lipoprotein concentrations and metabolism in various animal models. Am J Clin Nutr 1997, 65(5 suppl):1617S-1627S.
16. Center for Food Safety and Applied Nutrition, Office of Food Additive Safety. Agency response letter GRAS notice no. GRN 000283. September 4,2009.
17. Ens J.G., Ma D.W., Cole K.S., Field C.J., Clandinin M.T. An assessment of c9,t11 linoleic acid intake in a small group of young Canadians. Nutr Res 2001, 21(7):955-960.
18. Sinclair A.J., Attar-Bashi N.M., Li D. What is the role of alpha-linolenic acid for mammals?. Lipids 2002, 37(12):1113-1123.
19. Davis B.C., Kris-Etherton P.M. Achieving optimal essential fatty acid status in vegetarians: Current knowledge and practical implications. Am J Clin Nutr 2003, 78(3 suppl):640S-646S.
20. Burdge G. Alpha-linolenic acid metabolism in men and women: Nutritional and biological implications. Curr Opin Clin Nutr Metab Care 2004, 7(2):137-144.
21. Simopoulos A.P. Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: Their role in the determination of nutritional requirements and chronic disease risk. Exp Biol Med (Maywood) 2010, 235(7):785-795.
22. Welch A.A., Shakya-Shrestha S., Lentjes M.A., Wareham N.J., Khaw K.T. Dietary intake andstatus of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the product-precursor ratio [corrected] of alpha-linolenic acid to long-chain n-3 polyunsaturated fatty acids: Results from the EPIC-Norfolk cohort. Am J Clin Nutr 2010, 92(5):1040-1051.
23. Pawlosky R.J., Hibbeln J.R., Novotny J.A., Salem N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. JLipid Res 2001, 42(8):1257-1265.
24. Lattka E., Illig T., Koletzko B., Heinrich J. Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 2010, 21(1):64-69.
25. Harris W.S., Lemke S.L., Hansen S.N., et al. Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids 2008, 43(9):805-811.
26. Lemke S.L., Vicini J.L., Su H., et al. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: Randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr 2010, 92(4):766-775.
27. Whelan J., Gouffon J., Zhao Y. Effects of dietary stearidonic acid on biomarkers of lipid metabolism. JNutr 2012, 142(3):630S-634S.
28. Gibson R.A., Neumann M.A., Lien E.L., Boyd K.A., Tu W.C. Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013, 88:139-146.
29. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6 suppl):1505S-1519S.
30. Lauritzen L., Hansen H.S., Jorgensen M.H., Michaelsen K.F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brainand retina. Prog Lipid Res 2001, 40(1-2):1-94.
31. US Department of Health and Human Services, Food and Drug Administration. 21 CFR part 184 [docket no. 86G-0289]. June 5,1997.
32. Blasbalg T.L., Hibbeln J.R., Ramsden C.E., Majchrzak S.F., Rawlings R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 2011, 93(5):950-962.
33. Kris-Etherton P.M., Harris W.S., Appel L.J. Omega-3 fatty acids and cardiovascular disease: New recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003, 23(2):151-152. AHA Nutrition Committee. American Heart Association.
34. Fish, Fish Oils, n-3 Polyunsaturated Fatty Acids and Cardiovascular Health. PRO-067 2008, National Heart Foundation of Australia, National Heart Foundation of Australia, Canberra. 2nd ed.
35. Food Standards Agency and Department ofHealth. Scientific Advisory Committee on Nutrition. Advice on Fish Consumption: Benefits and Risks 2004, 1-222. The Stationary Office, Norwich, UK.
36. Freeman M.P., Hibbeln J.R., Wisner K.L., et al. Omega-3 fatty acids: Evidence basis for treatment and future research inpsychiatry. JClin Psychiatry 2006, 67(12):1954-1967.
37. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition, and Allergies (NDA). Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J 2010, 8(3):1461.
38. International Society for the Study of FattyAcids and Lipids. Recommendations for intake of polyunsaturated fattyacids in healthy adults. Published 2004. Accessed October 31,2013. http://www.issfal.org/statements/pufa-recommendations/statement-3.
39. Food and Drug Administration. Omega-3 fatty acids & coronary heart disease. Docket No. 2003Q-0401. Published September 8, 2004. Accessed October 31,2013. http://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073992.htm#omega3.
40. US Food and Drug Administration. Qualified health claims: Letter of enforcement discretion-Nuts and coronary heart disease. Docket No 02P-0505. Published July 14, 2003. Accessed October 31,2013. http://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073992.htm#nuts.
41. Bang H.O., Dyerberg J., Nielsen A.B. Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos. Lancet 1971, 1(7710):1143-1145.
42. Dyerberg J., Bang H.O., Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975, 28(9):958-966.
43. Mozaffarian D., Appel L.J., Van Horn L. Components of a cardioprotective diet: New insights. Circulation 2011, 123(24):2870-2891.
44. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274(17):1363-1367.
45. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. NEngl J Med 2002, 346(15):1113-1118.
46. Mozaffarian D., Gottdiener J.S., Siscovick D.S. Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 2006, 97(2):216-222.
47. Chung H., Nettleton J.A., Lemaitre R.N., et al. Frequency and type of seafood consumed influence plasma (n-3) fattyacid concentrations. JNutr 2008, 138(12):2422-2427.
48. Food and Drug Administration, Environmental Protection Agency. What you needto know about mercury in fish andshellfish. Updated 20042012. Accessed February 5,2013. http://water.epa.gov/scitech/swguidance/fishshellfish/outreach/advice_index.cfm.
49. Mozaffarian D., Shi P., Morris J.S., et al. Mercury exposure and risk of cardiovascular disease in two US cohorts. NEngl J Med 2011, 364(12):1116-1125.
50. Harris W.S., Pottala J.V., Sands S.A., Jones P.G. Comparison of the effects of fish and fish-oil capsules on the n3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr 2007, 86(6):1621-1625.
51. Harris W.S., Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides?. Curr Opin Lipidol 2006, 17(4):387-393.
52. Roche H.M., Gibney M.J. Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 2000, 71(1 suppl):232S-237S.
53. Skulas-Ray A.C., Kris-Etherton P.M., Harris W.S., West S.G. Effects of marine-derived omega-3 fatty acids on systemic hemodynamics at rest and during stress: A dose-response study. Ann Behav Med 2012, 44(3):301-308.
54. Cabo J., Alonso R., Mata P. Omega-3 fatty acids and blood pressure. Br J Nutr 2012, 107(suppl 2):S195-S200.
55. Mozaffarian D., Geelen A., Brouwer I.A., Geleijnse J.M., Zock P.L., Katan M.B. Effect of fish oil on heart rate in humans: A meta-analysis of randomized controlled trials. Circulation 2005, 112(13):1945-1952.
56. Wilk J.B., Tsai M.Y., Hanson N.Q., Gaziano J.M., Djousse L. Plasma and dietary omega-3 fatty acids, fish intake, and heart failure risk in the physicians' health study. Am J Clin Nutr 2012, 96(4):882-888.
57. Kromhout D., Giltay E.J., Geleijnse J.M. N-3 fatty acids and cardiovascular events after myocardial infarction. NEngl J Med 2010, 363(21):2015-2026. Alpha Omega Trial Group.
58. Zhao G., Etherton T.D., Martin K.R., West S.G., Gillies P.J., Kris-Etherton P.M. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. JNutr 2004, 134(11):2991-2997.
59. West S.G., Krick A.L., Klein L.C., et al. Effects of diets high in walnuts and flax oil on hemodynamic responses to stress and vascular endothelial function. JAm Coll Nutr 2010, 29(6):595-603.
60. Zatonski W., Campos H., Willett W. Rapid declines in coronary heart disease mortality in eastern Europe are associated with increased consumption of oils rich in alpha-linolenic acid. Eur J Epidemiol 2008, 23(1):3-10.
61. Kris-Etherton P.M., Hu F.B., Ros E., Sabate J. The role of tree nuts and peanuts in the prevention of coronary heart disease: Multiple potential mechanisms. JNutr 2008, 138(9):1746S-1751S.
62. King J.C., Blumberg J., Ingwersen L., Jenab M., Tucker K.L. Tree nuts and peanuts as components of a healthy diet. JNutr 2008, 138(9):1736S-1740S.
63. Banel D.K., Hu F.B. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: A meta-analysis and systematic review. Am J Clin Nutr 2009, 90(1):56-63.
64. Griel A.E., Kris-Etherton P.M., Hilpert K.F., Zhao G., West S.G., Corwin R.L. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 2007, 6:2.
65. Harris W.S., Mozaffarian D., Lefevre M., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. JNutr 2009, 139(4):804S-819S.
66. Dewell A., Marvasti F.F., Harris W.S., Tsao P., Gardner C.D. Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. JNutr 2011, 141(12):2166-2171.
67. Woods S.W. The economic burden of bipolar disease. JClin Psychiatry 2000, 61(suppl 13):38-41.
68. Hibbeln J.R. Fish consumption and major depression. Lancet 1998, 351(9110):1213.
69. Lin P.Y., Huang S.Y., Su K.P. Ameta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010, 68(2):140-147.
70. McNamara R.K., Hahn C.G., Jandacek R., et al. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007, 62(1):17-24.
71. Su K.P., Huang S.Y., Chiu C.C., Shen W.W. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003, 13(4):267-271.
72. Appleton K.M., Rogers P.J., Ness A.R. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010, 91(3):757-770.
73. Martins J.G. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: Evidence from a meta-analysis of randomized controlled trials. JAm Coll Nutr 2009, 28(5):525-542.
74. Heude B., Ducimetiere P., Berr C., EVA S. Cognitive decline and fatty acid composition of erythrocyte membranes-The EVA study. Am J Clin Nutr 2003, 77(4):803-808.
75. Beydoun M.A., Kaufman J.S., Satia J.A., Rosamond W., Folsom A.R. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The atherosclerosis risk in communities study. Am J Clin Nutr 2007, 85(4):1103-1111.
76. Conquer J.A., Tierney M.C., Zecevic J., Bettger W.J., Fisher R.H. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000, 35(12):1305-1312.
77. Schaefer E.J., Bongard V., Beiser A.S., et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch Neurol 2006, 63(11):1545-1550.
78. Dangour A.D., Allen E., Elbourne D., et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial. Am J Clin Nutr 2010, 91(6):1725-1732.
79. Yurko-Mauro K., McCarthy D., Rom D., et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010, 6(6):456-464.
80. Quinn J.F., Raman R., Thomas R.G., et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 2010, 304(17):1903-1911.
81. Muldoon M.F., Ryan C.M., Sheu L., Yao J.K., Conklin S.M., Manuck S.B. Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. JNutr 2010, 140(4):848-853.
82. Fortin P.R., Lew R.A., Liang M.H., et al. Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis. JClin Epidemiol 1995, 48(11):1379-1390.
83. Goldberg R.J., Katz J. Ameta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007, 129(1-2):210-223.
84. Yaqoob P., Calder P.C. Fatty acids and immune function: New insights into mechanisms. Br J Nutr 2007, 98(suppl 1):S41-S45.
85. Johnson G.H., Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: A systematic review of randomized controlled trials. JAcad Nutr Diet 2012, 112(7):1029-1041.
86. Mathias R.A., Sergeant S., Ruczinski I., et al. The impact of FADS genetic variants on omega6 polyunsaturated fatty acid metabolism in African Americans. BMC Genet 2011, 12:50.
87. Rett B.S., Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming western-type diets: A systematic review. Nutr Metab (Lond) 2011, 8:36.
88. Harris W.S., Mozaffarian D., Rimm E., et al. Omega-6 fatty acids and risk for cardiovascular disease: A science advisory from the American Heart Association nutrition subcommittee of the council on nutrition, physical activity, and metabolism; council on cardiovascular nursing; and council on epidemiology and prevention. Circulation 2009, 119(6):902-907.
89. Ramsden C.E., Zamora D., Leelarthaepin B., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: Evaluation of recovered data from the Sydney diet heart study and updated meta-analysis. BMJ 2013, 346:e8707.
90. Joseph S.V., Jacques H., Plourde M., Mitchell P.L., McLeod R.S., Jones P.J. Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. JNutr 2011, 141(7):1286-1291.
91. Raff M., Tholstrup T., Toubro S., et al. Conjugated linoleic acids reduce body fat in healthy postmenopausal women. JNutr 2009, 139(7):1347-1352.
92. Norris L.E., Collene A.L., Asp M.L., et al. Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. Am J Clin Nutr 2009, 90(3):468-476.
93. Riserus U., Arner P., Brismar K., Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002, 25(9):1516-1521.
94. Elmadfa I., Kornsteiner M. Dietary fat intake-A global perspective. Ann Nutr Metab 2009, 54(Suppl 1):8-14.
95. Mensink R.P., Zock P.L., Kester A.D., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77(5):1146-1155.
96. Kris-Etherton P.M. AHA Science Advisory. Monounsaturated fatty acids and risk of cardiovascular disease. American Heart Association. Nutrition Committee. Circulation 1999, 100(11):1253-1258.
97. Schwingshackl L., Strasser B., Hoffmann G. Effects of monounsaturated fatty acids on cardiovascular risk factors: A systematic review and meta-analysis. Ann Nutr Metab 2011, 59(2-4):176-186.
98. Jakobsen M.U., O'Reilly E.J., Heitmann B.L., et al. Major types of dietary fat and risk of coronary heart disease: A pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89(5):1425-1432.
99. Warensjo E., Sundstrom J., Vessby B., Cederholm T., Riserus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: A population-based prospective study. Am J Clin Nutr 2008, 88(1):203-209.
100. Bullo M., Garcia-Aloy M., Martinez-Gonzalez M.A., et al. Association between a healthy lifestyle and general obesity and abdominal obesity in an elderly population at high cardiovascular risk. Prev Med 2011, 53(3):155-161.
101. Kastorini C.M., Milionis H.J., Esposito K., Giugliano D., Goudevenos J.A., Panagiotakos D.B. The effect of Mediterranean diet on metabolic syndrome and its components: A meta-analysis of 50 studies and 534,906 individuals. JAm Coll Cardiol 2011, 57(11):1299-1313.
102. Nordmann A.J., Suter-Zimmermann K., Bucher H.C., et al. Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med 2011, 124(9):841-851.e2.
103. Martinez-Gonzalez M.A., Garcia-Arellano A., Toledo E., et al. A14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial. PLoS One 2012, 7(8):e43134.
104. Estruch R., Ros E., Salas-Salvado J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. NEngl J Med 2013, 368(14):1279-1290.
105. Kendall C.W., Josse A.R., Esfahani A., Jenkins D.J. Nuts, metabolic syndrome anddiabetes. Br J Nutr 2010, 104(4):465-473.
106. Kushi L.H., Doyle C., McCullough M., et al. American cancer society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012, 62(1):30-67.
107. Grande F., Anderson J.T., Keys A. Comparison of effects of palmitic and stearic acids in the diet on serum cholesterol in man. Am J Clin Nutr 1970, 23(9):1184-1193.
108. Eckel R.H., Jakicic J.M., Ard J.D., et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2013, [published online ahead of print November 7, 2013]. doi:10.1016/j.jacc.2013.11.003.
109. Micha R., Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids 2010, 45(10):893-905.
110. Mente A., de Koning L., Shannon H.S., Anand S.S. Asystematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009, 169(7):659-669.
111. Franz M.J., Bantle J.P., Beebe C.A., et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002, 25(1):148-198.
112. van Dam R.M., Willett W.C., Rimm E.B., Stampfer M.J., Hu F.B. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002, 25(3):417-424.
113. St-Onge M.P., Bosarge A. Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. Am J Clin Nutr 2008, 87(3):621-626.
114. St-Onge M.P., Ross R., Parsons W.D., Jones P.J. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res 2003, 11(3):395-402.
115. Katan M.B., Zock P.L., Mensink R.P. Effects of fats and fatty acids on blood lipids in humans: An overview. Am J Clin Nutr 1994, 60(6 suppl):1017S-1022S.
116. Bernstein A.M., Sun Q., Hu F.B., Stampfer M.J., Manson J.E., Willett W.C. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010, 122(9):876-883.
117. Mir P.S., McAllister T.A., Scott S., et al. Conjugated linoleic acid-enriched beef production. Am J Clin Nutr 2004, 79(6 suppl):1207S-1211S.
118. Craig-Schmidt M.C. World-wide consumption of trans fatty acids. Atheroscler Suppl 2006, 7(2):1-4.
119. Hulshof K.F., van Erp-Baart M.A., Anttolainen M., et al. Intake of fatty acids in western Europe with emphasis on trans fatty acids: The TRANSFAIR study. Eur J Clin Nutr 1999, 53(2):143-157.
120. Doell D., Folmer D., Lee H., Honigfort M., Carberry S. Updated estimate of trans fat intake by the US population. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2012, 29(6):861-874.
121. Vesper H.W., Kuiper H.C., Mirel L.B., Johnson C.L., Pirkle J.L. Levels of plasma trans-fatty acids in non-Hispanic white adults in the United States in 2000 and 2009. JAMA 2012, 307(6):562-563.
122. Nestel P., Noakes M., Belling B., et al. Plasma lipoprotein lipid and lp[a] changes with substitution of elaidic acid for oleic acid in the diet. JLipid Res 1992, 33(7):1029-1036.
123. Motard-Belanger A., Charest A., Grenier G., et al. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008, 87(3):593-599.
124. Hibbeln J.R., Nieminen L.R., Blasbalg T.L., Riggs J.A., Lands W.E. Healthy intakes of n-3 and n-6 fatty acids: Estimations considering worldwide diversity. Am J Clin Nutr 2006, 83(6 suppl):1483S-1493S.
125. Mozaffarian D., Micha R., Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010, 7(3):e1000252.
126. Ordovas J.M. Nutrigenetics, plasma lipids, and cardiovascular risk. JAm Diet Assoc 2006, 106(7):1074-1081.
127. Phillips C.M., Goumidi L., Bertrais S., et al. Dietary saturated fat modulates the association between STAT3 polymorphisms and abdominal obesity in adults. JNutr 2009, 139(11):2011-2017.